Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2019-06-25 Director's Dealing
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2019-06-25 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the approval of the third phase of a multi-year restructuring plan by the company's Board of Directors, including expected costs and savings. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a transcript, proxy, or earnings release. The document is a regulatory announcement of a significant corporate event (cost transformation plan approval and related financial expectations). Given the nature of Form 8-K filings and the content, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. The document length (5983 characters) and detailed content confirm it is not a brief announcement or a report publication notice. Therefore, the classification is RNS with high confidence.
2019-06-18 English
FORM 3/A
Director's Dealing
2019-06-05 English
FORM 4
Director's Dealing
2019-06-03 English
FORM SD CONFLICT MINERALS
Regulatory Filings Classification · 100% confidence The document is a Form SD filed with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the year ended December 31, 2018. It references Rule 13p-1 under the Securities Exchange Act and includes a Conflict Minerals Report as an exhibit. Form SD is a specialized regulatory filing for conflict minerals disclosure and does not constitute an annual report, audit report, or financial statement. The document is about compliance and disclosure rather than financial performance or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance filings that do not fit other specific categories.
2019-05-30 English
FORM 4
Director's Dealing
2019-05-22 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.